As Veklury’s sales slide, Gilead hopes for a quicker rebound from Biktarvy, other HIV drugs
As Veklury’s sales slide, Gilead hopes for a quicker rebound [...]
As Veklury’s sales slide, Gilead hopes for a quicker rebound [...]
GlaxoSmithKline’s Nucala beats AZ’s Fasenra to the IL-5 punch in [...]
FDA warns increased death risk for freshly approved myeloma drug, [...]
Teva ‘optimistic’ opioid settlement could come within year following historic [...]
‘I don’t like it:’ Biogen’s latest Alzheimer’s ad rouses fresh [...]
Lawmakers press FDA for answers about its plans to restart [...]
As GlaxoSmithKline works to get Shingrix back on track, an [...]
Pfizer, Johnson & Johnson settle high-profile Remicade biosim lawsuit on [...]
AstraZeneca’s newly acquired Soliris is overpriced in myasthenia gravis, cost [...]
CDMO Recipharm continues its rapid expansion with a second fill-finish [...]